Medical experts at Memorial Sloan-Kettering are leading numerous clinical trials to improve the detection and management of pancreatic cancer and to extend survival. Researchers are working to identify biomarkers for pancreatic cancer that will allow doctors to select the most-effective treatment for each patient. This information may also help to develop new targeted therapies for pancreatic cancer. Other clinical trials are investigating ways to reduce surgical complications, deliver therapies endoscopically, and reduce the side effects of radiation. Patients who are treated at Memorial Sloan-Kettering and are eligible for a clinical trial have access to promising new treatments before they are widely available.